This at-home panel delivers the lab data you need to have a productive, data-driven conversation about your weight management options
If you have been wondering whether your body mass index is high enough, low enough, or complicated enough to qualify, you are about to get a definitive answer
The role of glucagon in glucose intolerance and effects of GLP-1 based drugs on plasma glucagon
They are FDA-approved for type 2 diabetes and/or obesity
The strengths include that over a thousand consecutive patients were examined, and a comprehensive list of confounders was studied in our dataset
"When I treat patients in the diabetes clinic, I see a huge variation in response to these GLP-1-based medications and it is difficult to predict this response clinically," says endocrinologist Mahesh Umapathysivam, from Adelaide University in Australia